Purpose. Chilean patients with type 2 diabetes mellitus (T2DM) have a low rate of blood sugar control. We studied the effectiveness of a culturally sensitive family oriented intervention designed to improve metabolic control in primary care patients with uncontrolled T2DM. Methods. Patients with T2DM from three primary care clinics in Santiago, Chile were randomly selected for inclusion if they had a recent HbA1c >7%, were between 18 and 70 years old and lived with a family member. Patients from one clinic received the family oriented intervention; patients from the other two (control) clinics received standard care. The intervention involved family members in care and included family counselling during clinic visits, family meetings and home visits. The primary outcome was HbA1c, measured at 6 and 12 months. Results. A total of 243 patients were enrolled and 209 (86%) completed the study. The intervention was fully administered to only 34% of patients in the intervention clinic. The reduction in the HbA1c from baseline to 12 months was not significantly different between clinics. During the second 6-month period, when the intervention was more intensive, the patients in the intervention clinic significantly improved their HbA1c (P < 0.001) compared to the control patients. Conclusions. A family intervention for the control of T2DM was associated with a significant reduction in HbA1c when the intervention was provided. Incomplete implementation, low statistical power and potential confounding variables between groups could be some of the main factors that explain the lack of difference between clinics in the 12-month period.
Introduction
Type 2 diabetes mellitus (T2DM) is a health problem worldwide, particularly in Latin America, where its prevalence is expected to increase more than in other parts of the world. 1 In Chile, the prevalence of T2DM is 4.2%.
2 Although we have a lower rate of this disease than other nations, only 25% of patients have HbA1c <7%, much lower than other Latin American countries (43.2%), 3 USA (40.5%) 4 or Canada (51%). 5 Different interventions have been developed to control diabetes in primary care without satisfactory results, 6 indicating the need of new strategies for this disease management.
Different factors, particularly psychosocial, influence the control of diabetes. [7] [8] [9] [10] Several of these pertain to family life and have been shown to correlate with metabolic control. For instance, more family support and better family perception have been associated with better glycaemic control. [11] [12] [13] [14] [15] The cause of this is not completely understood. Members of more supportive families might have healthier behaviours, higher medication adherence and lower levels of stress that could explain their superior outcomes. Thus, involving family members may improve the management diabetes. Despite this, few family interventions have been developed to improve control in patients with chronic diseases. Morisky et al. 16 studied hypertension and demonstrated that counselling family members during home visits improved appointment keeping, body weight, blood pressure control and mortality after 5 years. In diabetes, interventions that include family members have been associated with improvement in metabolic control in type 1 diabetes mellitus but not in T2DM. 17 Therefore, the purpose of this study was to assess the effectiveness of a culturally sensitive family oriented intervention designed to improve metabolic control in primary care patients with uncontrolled T2DM.
Methods

Setting
We used a controlled clinical trial in three primary care clinics (Fig. 1) . The clinics were located in an urban area in south-east Santiago, Chile. Two clinics were part of the Primary Healthcare Network of the Pontificia Universidad Cató lica de Chile: Juan Pablo II (intervention clinic) and San Alberto Hurtado (control clinic 1: CC1). Each of these clinics serves a population of 22 000 individuals and both are similar in the quantity of human resources and types of health programmes for diabetic patients. The intervention clinic serves people with a monthly family income between USD 200 and 500, and the CC1, people with an income between USD 500 and 1000 a month. The third clinic, El Roble (control clinic 2: CC2), is a public primary care clinic located near the intervention centre and administered by the local municipality. It serves more people than the other clinics (35 000), with similar socio-economic characteristics as those served by the intervention clinic. It also has a similar ratio of physicians and nurses to the population served. The three clinics follow the structured care for patients and guidelines of the Chilean Ministry of Health and use electronic records.
Sample
The sample consisted of patients with T2DM between 18 and 70 years old, with an HbA1c >7% in the preceding 3 months. Patients were randomly selected from the databases of the clinics and were invited by telephone or home visit to participate in the study. As an inclusion criteria, patients had to live in the same household with a significant family member >15 years. Patients were excluded from the study if they were hospitalized during the 3 months prior the HbA1c measurement or had a cognitive disorder that limited their participation.
The sample size was determined to provide a statistical power of 80%, a confidence interval of 95% and to demonstrate an expected effect of a 10% decrease in the HbA1c. We considered this magnitude of effect because it has been associated with a 21% reduction in T2DM-related morbidity and mortality. 18 This analysis indicated that each centre had to include at least 72 patients.
Procedures
Trained interviewers asked patients for inclusion and exclusion criteria. If the patient was eligible and wanted to participate in the study, he or she was asked to read and sign an informed consent agreement. Following this, the participants completed an in-person interview, which was repeated at 12 months. HbA1c was measured at 6 and 12 months after the intervention began. Baseline HbA1c was the value considered for recruitment. All procedures and consent forms were reviewed and approved by the Ethics Review Board of the School of Medicine of the Pontificia Universidad Cató lica de Chile.
Outcomes
The primary outcome variable was HbA1c at 12 months. Secondary outcomes were family functioning style, depressive symptoms, health behaviours (diet and exercise), medication adherence and knowledge of diabetes.
Instruments
Assessments at baseline and 12 months included a 138-item questionnaire. This survey was divided into eight sections: diabetes and co-morbidities, medication and adherence, use of health services, health behaviours, family and family functioning style, mood and anxiety, diabetes knowledge and sociodemographics.
Family functioning style was measured with the Family Functioning Style Scale validated in Chile. 19 This instrument assesses seven family factors on a fivepoint scale and has been used in Chilean primary care. Symptoms of depression and anxiety were assessed FIGURE 1 Study design with Goldberg's General Health Questionnaire validated in Chile. 20 Medication adherence was assessed with Moriski-Green Scale validated in Spanish 21 and knowledge of diabetes with the Spanish version of the Diabetes Knowledge Questionnaire-24. 22 
Intervention
The intervention was based in the Innovative Care for Chronic Conditions Framework. 23 This model is an adaptation of the Chronic Care Model designed by Wagner et al. 24 to improve the control of chronic diseases.
Family members were encouraged to be involved in the care of their diabetic relatives (Fig. 1) . By the end of the intervention, each patient should have had participated in two interdisciplinary family meetings or home visits where providers talked about family or other psychosocial factors that could interfere with their diabetes control. These activities were guided through semi-structured interviews, and at the end of the activities, patients and relatives signed an agreement making a commitment to change. To reinforce the importance of the family, during home visits, families received a recipe book for diabetes and during family meetings, they received a framed family picture. In addition, patients had to receive at least one individual counselling session and one counselling session with their relatives where the importance of family support strategies were discussed. Also, during the 12-month intervention period, patients and relatives were encouraged to attend multifamily group sessions, where health behaviours and control strategies were discussed.
All providers of the intervention clinic were trained in motivational interviewing and family counselling and clinicians that guided multifamily groups were trained in participative education for adults. Reports about the fulfilment of the intervention and motivational activities were carried out monthly, where health care teams that had the highest execution were awarded.
As part of the intervention, the organization of the clinic changed towards a family-oriented health centre. All members of the health care team promoted family participation in the care of T2DM patients. As example, medical assistants, pharmacists and administrative staff counselled patients and family members when measuring vital signs, dispensing medications or making appointments. Control patients only received the usual care according to the guidelines for T2DM of the Chilean Ministry of Health.
Statistical analysis
Data analysis was performed with SPSS software v.16.1 (Chicago, IL). Per protocol and intention to treat (ITT) analyses were performed. For the ITT analysis, the last observation was carried forward when there was a missing value of the outcome studied, assuming an absence of variation in the results. For the analysis of changes in the outcomes between the final and baseline measures, we used a paired t-test for continuous variables and McNemar test for binary variables. To compare differences between health care centres, we used an analysis of variance and Bonferroni test for multiple comparisons of continuous variables and a chi-square or Fisher's exact test for discrete variables. Potential confounders were tested one at a time to model the change of the HbA1c. We examined the following variables: age, illiteracy, years of education, family income, insulin use, comorbidities, knowledge of diabetes and the presence of depressive symptoms. A univariate analysis was performed to model the changes in HbA1c, considering only the statistically significant baseline differences between health centres. Estimated marginal means were analysed through the multiple comparison of Bonferroni.
Resulting two-tailed P-values of <0.05 were considered statistically significant.
Results
Sample description
As seen in Figure 1 , from a total of 433 eligible patients with uncontrolled T2DM, the sample included 243 patients (56.1%). Patients' baseline characteristics are summarized in Table 1 . Most of them were women, 50 years old and with a family income <$250 USD per month. The initial HbA1c of patients in the intervention centre was significantly higher than the patients from both control centres. Compared to the patients from the intervention clinic, CC1 patients had more years of education, more family income, fewer co-morbidities, better health behaviours, different type of diabetes treatment, greater knowledge of diabetes and fewer depressive symptoms. Compared to the intervention centre patients, CC2 patients were older and more frequently illiterate, had fewer comorbidities and fewer depressive symptoms.
After 1 year of follow-up, 35 patients (14.4%) dropped out, mainly from CC1 (n = 19) because they could not be found (n = 21, 60%) or because they moved from their homes (n = 14, 40%). There were no significant differences in sex or age distribution among the lost patients between health centres. Table 2 shows the fulfilment of the main components of intervention at 6 and 12 months. Only 28 patients (34%) received all the proposed activities, mainly during the second 6-month period.
Outcomes
At 12 months, HbA1c was significantly reduced in the intervention clinic from 10.3 to 9.2% (P < 0.001) and in CC1 from 9.5 to 8.6% (P < 0.01). We did not find statistically significant differences between health Family Practice-an international journal centres considering per protocol and ITT analyses. After adjusting for main baseline differences, the differences between clinics were still not significant (Fig. 2) .
Because of the low intervention fulfilment during the first 6-month period, we also analysed the HbA1c during the second part of the study, where most of the intervention was carried out (Table 3) . Per protocol, ITT and baseline adjusted analysis showed a statistically significant reduction in the HbA1c in the intervention clinic compared to the CC1 (P < 0.001) and CC2 (P < 0.01). Regression analysis did not show differences between the different elements of the intervention in the HbA1c.
We observed a significant reduction in depressive symptoms in the intervention clinic compared to CC1 (Table 4) . However, no significant changes occurred at the intervention clinic and the control centres between baseline and 12 months in family functioning style, health behaviours, medication adherence and knowledge of diabetes. Also, all health clinics had similar changes in medication to control diabetes.
In addition, at the end of the study, we assessed the satisfaction of patients and providers with the intervention provided. All providers considered the intervention to be globally useful for metabolic control. Most patients (97%) perceived that the family orientation of the clinic and the family activities helped them to manage the disease.
Discussion
Our trial showed a statistically significant reduction of 0.9% in HbA1c after the implementation of a family Data are presented at number (%) or mean (±SD). *P < 0.05, **P < 0.01, ***P < 0.001 compared to the intervention clinic. a Details of these scales can be obtained from the original publications. [18] [19] [20] [21] programme in the intervention clinic during 12 months. Only, when the intervention was more intensive, during the second 6-month period, the patients in the intervention clinic significantly improved their HbA1c compared to control patients (Table 3) . Similar results were found in the meta-analysis of eight clinical trials of family interventions for type 1 diabetes, which showed a pooled effect of 0.6% reduction in the HbA1c. 17 Unfortunately, family interventions have not shown improvement in the metabolic control of type 2 diabetes. Gilliland et al. 25 reported an increase in the HbA1c after 1 year of a lifestyle counselling programme that included families and friends. Although all study groups had increases in the HbA1c, the increase in the intervention group was significantly lower than in the control group. In a randomized clinical trial involving patients with T2DM and obesity, a behavioural weight control programme that included spouses to support their partners achieved a non-significant 1.2% reduction in the HbA1c after 12 months. 26 Even though published studies have not demonstrated that family interventions improve management of T2DM, an additional trial and a systematic review are under way because of the potential benefits. 9, 27 The effect on HbA1c observed in the intervention clinic was similar to that in CC1 and not significantly higher from that in CC2 during the whole trial period. The lack of difference in the HbA1c reduction between the intervention clinic and the two control clinics could be explained by several factors. First, the three cohorts were significantly different at baseline in terms of socioe-conomic status, educational level, co-morbidities, HbA1c, knowledge of diabetes and presence of depressive symptoms (Table 1 ). All these factors have been associated with diabetes control.
2,7-9,28 However, after conducting single and multiple adjustments for these variables, there were still no significant differences between groups (Fig. 2) . Also, because of the difference in response and follow-up rates between centres, we think that we could have had a potential selection bias in the sample.
Third, intervention fulfilment was incomplete. Only 34% of patients received all the proposed activities, and most of these were administered during the second 6 months (Table 2) . During this period, we observed a significant improvement in the metabolic control compared to control patients (Table 3) . Also, the reduction of HbA1c was more important when patients completed all the elements of the intervention. The success of this trial could be explained because of the dose achieved during the second period of the trial was more intensive than other studies that have assessed family interventions for T2DM. 6, 17, 25, 26 This means that family orientation contributes to the metabolic control of T2DM patients but requires a high dose of intervention to be significant. Since we Family Practice-an international journal assessed a complex intervention, it is difficult to analyse which element worked better independently. Many reasons could explain the lack of adherence to the activities proposed across the year of the trial.
Since the intervention required an organizational change, an initial time to adopt the intervention, confirm adherence to the new framework and correct mistakes should have been added at the beginning of the trial. 29 The health care team progressively learnt how to administer the intervention over time, particularly for the most important family activities: family meetings and home visits. Also, providers argued that the duration of regular clinical appointments (15 minutes) was too short to allow a family orientation. Although a well-controlled study that directly compares individual patient and family modes of intervention has not been reported, family-based care may be cost-efficient and provide cost savings. Naylor et al. 30 evaluated, in hospitalized elderly patients, whether a comprehensive discharge plan that addressed family care management reduced readmissions, hospital length of stay, acute care visits after discharge and costs. After 24 weeks, the programme diminished admissions, length of hospital stays and costs. Future trials should consider the dose of the family intervention provided and the barriers detected in this trial to achieve higher effectiveness and adherence to family-based programmes.
In our study, not only was the adherence of the intervention less than planned but so was its quality. Even though all providers were trained in family assessment and interview skills, time is required to fully develop expertise in the family systems model. We used semistructured interviews to standardize activities, nonetheless, the interventions provided to different patients and families across providers varied significantly. Recording family meetings or home visits and giving feedback to providers could have helped achieve a more uniform intervention for all patients and families.
The ideal design to explore the effectiveness of a complex intervention, such as the one proposed in this study, is a cluster randomized controlled trial. 31 Because we did not know the magnitude of effect achievable with this strategy and estimated a high level of contamination in the intervention centre, we chose a controlled trial design instead of a randomized trial as a pilot study. We selected the centres based on similarities in the ways in which the clinics operated (CC1) and the sociodemographic characteristics of the patients (CC2). In spite of our efforts to choose the best comparative centres, the baseline characteristics of patients in both control clinics were substantially different from the patients at the intervention centre, and this naturally limited their comparison.
Our hypothesis was based on the idea that involving family members through a set of family and educational activities could improve medication adherence, health behaviours, knowledge of diabetes, family functioning style and depressive symptoms to finally improve the metabolic control of T2DM in 1 year. Since few reported studies have been performed on family interventions for the management of chronic diseases, the type, dose and duration of the intervention needed to produce changes in the studied outcome variables are unknown. Our results showed a decreasing trend in HbA1c levels mainly in the latter 6 months of the study, when the intervention was more intense (Fig. 2,  Table 3 ). In spite of this tendency, the patients in the intervention group did not show changes in the intermediate variables expected to ultimately improve metabolic control (Table 4) . Further research is needed to identify which factors are affected by families and most likely to improve patient health.
Considering the importance of diabetes and the difficulties in achieving metabolic control, new strategies need to be developed. Culturally sensitive interventions for patients with T2DM have improved disease Data are presented at number (%) or mean (±SD). *P < 0.05, **P < 0.01, ***P < 0.001 compared to baseline value of the clinic. T _ T _ T _ : P < 0.001 compared to the effect of the intervention clinic. a Details of these scales can be obtained from the original publications. [18] [19] [20] [21] control in Hispanics and other populations. 32, 33 The intervention that we used was developed based on the views and values of patients, family members and providers. The high level of satisfaction with the programme reflects how the intervention considered local beliefs and principles and was appropriate for patients and providers. Future research should be based on culturally sensitive interventions.
In summary, the present study showed that when the intervention was administered, it was associated with a significant reduction in HbA1c, but the differences during the total research period did not reach statistical significance. Lack of effectiveness, incomplete implementation, low statistical power and potential confounding variables between groups could be some of the main factors that explain these results.
